Dosing underway in Moderna's Phase 2/3 study of mRNA-1345 RSV vaccine
November 18 2021 - 7:25AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Sep 2023 to Sep 2024